Cardiometabolic Insights in HCM: The Emerging Role of SGLT Inhibition

Get up to speed with Dr. Sharlene Day as she reviews the scientific rationale and emerging evidence for SGLT inhibition with sotagliflozin in HCM.

ReachMD Healthcare Image
Media formats available
  • Completing the pre-test is required to access this content.
    Pre-Survey
    Completing the pre-survey is required to access this content.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free